| Literature DB >> 28521827 |
Alsiddig Osama1, Sufyan Awadelkarim2,3, Amna Ali3.
Abstract
BACKGROUND: Sarcocephalus latifolius is used as a traditional medicine for curing many diseases in Sudan. The main objective of the current study was to determine the antioxidant activity and acetylcholinesterase inhibition (AChEI) of S. latifolius, and to estimate its total phenolic and flavonoid contents.Entities:
Keywords: Acetylcholinesterase; Antioxidant; Flavonoids; Gcms; Phenolics; S. latifolius
Mesh:
Substances:
Year: 2017 PMID: 28521827 PMCID: PMC5437551 DOI: 10.1186/s12906-017-1772-6
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Standard curves of (a) Gallic acid and (b) Quercetin shows the absorbance against concentration
Yield percentages, Total phenolic and flavonoid contents of ethanolic extract and solvent fractions of S. latifolius
| Sample | Extraction yield ( | Phenolic content (mg /g GAE) | Total flavonoid (mg/g QE) |
|---|---|---|---|
| Crude | 47.33 | 78.21 ± 2.4 | 91.36 ± 0.84 |
| Hexane | 6.18 | 98.78 ± 2.1 | 81.01 ± 0.012 |
| CHCl3 | 1.64 | 71.49 ± 0.5 | 118.29 ± 0.21 |
| EtOAc | 3.09 | 86.12 ± 0.7 | 80.23 ± 0.03 |
| BuOH | 19.09 | 56.20 ± 1.23 | 94.32 ± 0.71 |
| H2O | 70.91 | 83.20 ± 3.7 | 40.22 ± 0.28 |
Preliminary screening of secondary metabolites in the fractions of S. latifolius
| Family of compound | Type of test | interference | ||||
|---|---|---|---|---|---|---|
|
| CHCl3 | EtOAc | n-BuOH | H2O | ||
| Phenols | FeCl3 | +v | +v | +v | +v | +v |
| Tannins | FeCl3 | -v | +v | +v | +v | +v |
| Flavonoids | KOH | +v | +v | +v | +v | +v |
| Alkaline | +v | +v | +v | +v | +v | |
| Lead acetate | +v | +v | +v | +v | +v | |
| Quinones | H2SO4 | -v | +v | +v | +v | +v |
| Alkaloids | Dragendorff’s | +v | +v | +v | +v | +v |
| Wagner’s | +v | +v | +v | +v | +v | |
| Triterpenes | Salkowski | +v | +v | +v | +v | +v |
| Diterpenes | Copper acetate | -v | -v | -v | -v | -v |
| Steroids | Salkowski | +v | +v | +v | +v | +v |
| Saponins | Forth | -v | +v | +v | -v | +v |
+ve positive -ve negative
Fig. 2Comparison charts of (a) Total phenolic content. b Total flavonoid content of ethanolic extract and solvent fractions of S. latifolius
Antioxidant activity (%RSA and IC50) of solvent fractions of S. latifolius
| Sample | % RSA | IC50 (mg/ml) |
|---|---|---|
| Hexane | 76 ± 0.02 | 0.098 ± 0.08 |
| CHCl3 | 86 ± 0.03 | 0.099 ± 0.029 |
| EtOAc | 84 ± 0.03 | 0.148 ± 0.33 |
| BuOH | 83 ± 0.02 | 0.104 ± 0.19 |
| H2O | 79 ± 0.10 | 2.015 ± 0.3 |
Fig. 3Percentage of RSA of S. latifolius ehanolic extract and solvent fractions
Fig. 4Comparison Chart of Antioxidant potentials of S. latifolius fractions with the decrease of concentration (IC50 evaluation)
GC-MS spectral analysis of hexane fraction of S. latifolius bark
| Peak no. | R. Time | Area % | Compunde name | Molecular Formula | Mass |
|---|---|---|---|---|---|
| 1 | 13.736 | 1.68 | 5,5-Dimethyl-1,5-oxasilonan-9-one | C9H18O2Si | 186 |
| 2 | 15.467 | 5.67 | Quinic acid | C7 H12 O6 | 192 |
| 3 | 19.188 | 0.29 | Pentadecanoic acid, methyl ester | C16 H32 O2 | 256 |
| 4 | 19.425 | 0.67 | Ethyl (2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate | C12H14O4 | 222 |
| 5 | 19.805 | 6.89 | Pentadecanoic acid | C15H30O2 | 242 |
| 6 | 20.147 | 2.20 | Palmitic acid ethyl ester | C18 H36 O2 | 284 |
| 7 | 20.761 | 0.53 | 2-Cyclopropylideneadamantane | C13H18 | 174 |
| 8 | 22.455 | 16.49 | Oleic Acid | C18H34O2 | 282 |
| 9 | 22.694 | 3.23 | Methyl linoleate | C19 H34 O2 | 294 |
| 10 | 22.765 | 1.64 | Ethyl octadec-9-enoate | C20H38O2 | 310 |
| 11 | 22.814 | 0.48 | Linolenic acid methyl ester | C19 H32 O2 | 292 |
| 12 | 23.122 | 3.91 | Heptadecanoic acid, ethyl ester | C19 H38 O2 | 298 |
| 13 | 25.920 | 14.21 | Oelic acid amide | C18 H35 N O | 281 |
| 14 | 25.994 | 0.23 | Oelic acid amide | C18 H35 N O | 281 |
| 15 | 26.187 | 0.44 | Palmitic acid ethyl ester | C18 H36 O2 | 284 |
| 16 | 26.265 | 0.60 | Stearic acid amide | C18H37NO | 283 |
| 17 | 26.509 | 0.43 | 2-Pentyl-2-nonenal | C14H26O | 210 |
| 18 | 26.761 | 0.43 | Oxirane, hexadecyl- | C18H36O | 268 |
| 19 | 28.299 | 0.48 | Octadecanal | C18H36O | 268 |
| 20 | 28.665 | 9.23 | Phthalic acid, mono-(2-ethylhexyl) ester | C16H22O4 | 278 |
| 21 | 29.192 | 0.97 | Ethyl palmitate | C18 H36 O2 | 284 |
| 22 | 29.881 | 19.50 | Cinchol | C29 H50 O | 414 |
| 23 | 32.086 | 0.57 | Ethyl docosanoate | C24H48O2 | 368 |
| 24 | 32.642 | 1.64 | Spinacene | C30H50 | 410 |
| 25 | 33.176 | 0.59 | 3-[(Trimethylsilyl)oxy]lanosta-8,24-diene | C33H58OSi | 498 |
| 26 | 33.343 | 1.44 | Lupenyl acetate | C32H52O2 | 468 |
| 27 | 35.907 | 3.46 | Stigmast-4-en-3-one | C29H48O | 412 |
| 28 | 38.248 | 1.09 | Cholesteryl bromide | C27 H45 Br | 448 |
| 29 | 38.974 | 1.01 | Vitamin E | C29H50O2 | 430 |
GC-MS spectral analysis of chloroform fraction of S. latifolius bark
| Number | R. Time | Area % | Compound name | Molecular Formula | Mass |
|---|---|---|---|---|---|
| 1 | 13.735 | 2.97 | 5,5-Dimethyl-1-oxa-5-silacyclononanone-9 | C9H18O2Si | 186 |
| 2 | 14.635 | 0.29 | 9-Eicosene, (E)- | C20H40 | 280 |
| 3 | 15.989 | 1.99 | 2H–Pyran-2-one, 5-ethylidenetetrahydro-4-(2-hydroxyethyl)- | C9H14O3 | 170 |
| 4 | 17.029 | 0.85 | 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol | C10H12O3 | 180 |
| 5 | 17.334 | 0.35 | 1-Heptadecene | C17H34 | 238 |
| 6 | 18.302 | 0.84 | p-Hydroxycinnamic acid, ethyl ester | C11H12O3 | 192 |
| 7 | 19.187 | 0.35 | 9-Octadecenoic acid, 12-(acetyloxy)-, methyl ester, [R-(Z)]- | C21H38O4 | 354 |
| 8 | 19.361 | 0.18 | 7,9-Di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione | C17H24O3 | 276 |
| 9 | 19.422 | 0.15 | alpha.-D-Xylofuranose, 1,2-O-isopropylidene-5-(t-butyldimethylsilyl)- | C14H28O5Si | 304 |
| 10 | 19.800 | 5.89 | Pentadecanoic acid | C15 H30 O2 | 242 |
| 11 | 20.115 | 0.30 | 9-Tricosene, (Z)- | C23H46 | 322 |
| 12 | 20.360 | 7.84 | 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- | C10 H8 O4 | 192 |
| 13 | 20.761 | 0.62 | Bicylo[4.1.0]heptane, 7-bicyclo[4.1.0]hept-7-ylidene- | C14H20 | 188 |
| 14 | 21.139 | 0.22 | Trimethylsilyl 3-methoxy-4-(trimethylsilyloxy)cinnamate | C16H26O4Si2 | 338 |
| 15 | 21.769 | 0.31 | 9-Octadecenoic acid (Z)-, methyl ester | C19H36O2 | 296 |
| 16 | 21.996 | 25.46 | 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- | C9 H8 O4 | 180 |
| 17 | 22.450 | 9.78 | Oleic Acid | C18H34O2 | 282 |
| 18 | 22.762 | 3.28 | Octadecanoic acid | C18H36O2 | 284 |
| 19 | 23.104 | 1.19 | 1-Hexadecene | C16 H32 | 224 |
| 20 | 23.740 | 0.61 | 9,12-Octadecadienoic acid (Z,Z)- | C18H32O2 | 280 |
| 21 | 25.816 | 0.39 | O O′-BIPHENOL, 4,4’,6,6’-TETRA-T-BUTYL- | C28 H42 O2 | 410 |
| 22 | 25.909 | 1.08 | 9-Octadecenamide, (Z)- | C18 H35 N O | 281 |
| 23 | 26.155 | 0.93 | 1-Nonadecene | C19H38 | 266 |
| 24 | 28.301 | 0.19 | Oxirane, heptadecyl- | C19H38O | 282 |
| 25 | 28.662 | 1.17 | 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester | C16H22O4 | 278 |
| 26 | 29.163 | 1.28 | 1-Nonadecene | C19H38 | 266 |
| 27 | 29.732 | 1.15 | gamma.-Sitosterol | C29H50O | 414 |
| 28 | 32.053 | 1.83 | 1-Triacontanol | C24H50O | 354 |
| 29 | 35.350 | 1.02 | 17-Pentatriacontene | C35H70 | 490 |
| 30 | 35.848 | 5.09 | Methyl commate C | C31 H50 O4 | 486 |
| 31 | 38.123 | 22.40 | Lup-20 (29)-en-3-ol, acetate, (3.beta.)- | C32H52O2 | 468 |
Fig. 5GC-MS chromatogram for hexane fraction of S. latifolius bark
Fig. 6GC-MS chromatogram for chloroform fraction of S. latifolius bark
The cytotoxic effect (expressed as % inhibition and IC50 values) of hexane and chloroform fractions of S. latifolius tested at 125, 250 and 500 μg/ml against Vero cells
| Code of extract | Concentration (μg/ml) | IC50 (μg/ml) | IC50 | ||
|---|---|---|---|---|---|
| Inhibition % ± SD | |||||
| 500 | 250 | 125 | |||
| Hexane | 55.3 ± 0.04 | 50.4 ± 0.02 | 40.9 ± 0.03 | 277.8 | >100 |
| Chloroform | 67.6 ± 0.08 | 55.0 ± 0.01 | 35.9 ± 0.05 | 224.9 | >100 |
| Control | 95.3 ± 0.00 | <30 | |||
IC50 < 30 μg/ml: High toxic. Control = triton was used as positive control at 0.2 μg/ml. the maximum concentration used was 500 μg/ml